Fecal Microbial Transplant Enema for Liver Cirrhosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, VALiver Cirrhosis+1 MoreFecal Microbial Transplant Enema - Drug
Eligibility
21 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new way to treat confusion in patients with end stage liver disease or cirrhosis, by replacing their bowel bacteria with healthy stool from another person.

Eligible Conditions
  • Liver Cirrhosis
  • Liver Encephalopathy

Treatment Effectiveness

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: 6 months

Month 6
Sickness Impact Profile change
Month 6
EncephalApp performance change
Hepatic Encephalopathy
6 months
Adverse events related to FMT
Change in microbial diversity in saliva
Change in microbial diversity in stool
Serious adverse events related to FMT

Trial Safety

Trial Design

4 Treatment Groups

Group 2: Oral FMT and rectal placebo
1 of 4
Group 3: Oral placebo and rectal FMT
1 of 4
Group 1: Dual Oral and rectal FMT
1 of 4
Placebo
1 of 4

Active Control

Experimental Treatment

Non-Treatment Group

60 Total Participants · 4 Treatment Groups

Primary Treatment: Fecal Microbial Transplant Enema · Has Placebo Group · Phase 1 & 2

Group 1: Dual Oral and rectal FMTExperimental Group · 2 Interventions: Fecal Microbial Transplant Enema, Fecal Microbial transplant Capsules · Intervention Types: Drug, Drug
Group 2: Oral FMT and rectal placebo
Drug
ActiveComparator Group · 1 Intervention: Fecal Microbial transplant Capsules · Intervention Types: Drug
Placebo
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other
Group 3: Oral placebo and rectal FMTActiveComparator Group · 2 Interventions: Fecal Microbial Transplant Enema, Placebo · Intervention Types: Drug, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,494 Previous Clinical Trials
2,724,254 Total Patients Enrolled
3 Trials studying Liver Cirrhosis
640 Patients Enrolled for Liver Cirrhosis
Jasmohan S. Bajaj, MD MSPrincipal InvestigatorHunter Holmes McGuire VA Medical Center, Richmond, VA

Eligibility Criteria

Age 21 - 75 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Could I be accepted as a participant in this medical trial?

"This clinical trial is recruiting 60 adults between the ages of 21 and 75 that have been diagnosed with hepatic coma. In addition to this prerequisite, female participants must agree to use reliable contraceptive measures from 10 days prior to their involvement in the study until 30 days after its completion. Also, these patients must meet one or more of the following criteria: Liver Biopsy/Radiologic evidence for varices/cirrhosis/portal hypertension, Platelet count <100K or AST/ALT ratio>1, Endoscopic proof for portal gastropathy/varices, Fibroscan values suggestive of cirrhosis on treatment for" - Anonymous Online Contributor

Unverified Answer

To what extent is the participant pool for this clinical trial expanding?

"Affirmative. The database of clinicaltrials.gov divulges that this analysis is currently searching for research subjects, with the first post having been made on July 29th 2019 and its most recent update being recorded on March 23rd 2022. 60 people are required to be enrolled at a single site." - Anonymous Online Contributor

Unverified Answer

Are there any vacancies for enrolment in this experiment?

"Verified. According to clinicaltrials.gov, this medical trial is still enrolling participants; it was first advertised on July 29th 2019 and its details were last modified on March 23rd 2022. The study requires 60 individuals from a single hospital site." - Anonymous Online Contributor

Unverified Answer

Does this trial include individuals above the age of majority?

"Per the outlined stipulations, only individuals aged 21 to 75 may join this trial." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.